国际皮肤性病学杂志    2001 27 (6): 326-328   ISSN: 2096-5540  CN: 32-1880/R   抗病毒新药——正二十二醇 钟连生综述1, 马道铭审校2 1. 中国医学科学院皮肤病研究所; 2. 中国协和医科大学皮肤病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Marcelletti JF,Pope LE.Khalil MH,et al.Lidakol.Drugs Fut,1992,17(19):879-882. [2] Katz DH,Marcelletti JF,Khalil MH,et al.Antiviral activity of 1-do-c osanol,an inhibitor of lipid-enveloped viruses including herpes simplex.Proc Natl Acad Sci USA,1991,88(23):10825-10829. [3] Scolaro M J,Gunnill LB,Pope LE,et al.The antiviral drug docosanol as atreatment for Kaposi's sarcoma lesions in HIV type 1-infected patients:apilot clinical study.MDS Res Hum Retroviruses,2001.17 (1):35-43. [4] Pope LE,Marcelletti JF,Katz LR,et al.The anti-herpes simplex virus ac tivity of n-docosanol includes inhibition of the viral entry process.Antiviral Res,1998,40:85-94. [5] Pope LE,Macelletti JF,Katz LR,et al.Anti-herpes simplex virus activity ofn-docosanol correlates with intracellular metabolic conversion of the drug.J Lipid Res,1996,37(10):2167-2178. [6] Fuller AO,Spear PG.Anti-glycoprotein D antibodies that permit adsorptionbut block infection by herpes simplex virus I prevent virion-cell fusion atthe cell surface.Proc Natl Acad Sci USA,1987,84(15):5454-5458. [7] Montgomery RI,Warner MS,Lum BJ,et al.Herpes simplex virus-I entry Zinto cells mediated by a novel member of the TNF/NGF receptor family.Cell,1996,87(3):427-436. [8] Roos DS,Choppin PW.Biochemical studies on cell fusion.Ⅱ.Control oflfusion response by lipid alteration.J Cell Biol,1985.101 (4):1591-1598. [9] Alrabiah FA,Sacks SL.New antiherpesvirus agents:Their targets and ther-apeutic potential.Drugs,1996,52(1):17-32. [10] Habbema L,De Boulle K,Roders GA,et al.n-Docosanol 10% cream in thetreatment of recurrent herpes labialis:a randomised,double-blind,placebo-controlled study.Acta Derm Venereol(Stockh),1996,76(6):479-481. [11] Sacks SL,Thisted RA,Jones TM,et al.Clinical efficacy of topical do-cosgnol 10% cream for herpes simplex labialis:A multicenter,randomized,placebo-controlled trial.J Am Acad Dermatol,2001,45(2):222-230. [12] Mihalcea AM,Smith DL,Monini P,et al.Treatment update for AIDS-relat-ed Kaposi's sarcoma.AIDS,1999,13(Suppl A):S215-S225. [13] Khalil MH,Marcelletti JF,Katz LR,et al.Topical applicatnon of docosanol-or stearic acid-containing creams reduces severity of phenol burn wounds inmice.Contact Dermatitis,2000,43(2):79-81. [14] Safrin S Assaykeen T,Follansbee S,et al.Foscamet therapy for acyclovir resistant mucocutaneous herpes simplex virus inlection in 26 AIDS pa-tients:Preliminary data.J Infect Dis,1990,161 (6):1078-1084. 通讯作者: